A live vaccine to Staphylococcus aureus infection.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Development of a Conserved Chimeric Vaccine for Induction of Strong Immune Response againstVaccines · 2021
   Article
2. Identification of CD4Biotechnologia · 2021
   Article
3. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients.Cell death discovery · 2020
   Article
4. Dangerous Pathogens as a Potential Problem for Public Health.Medicina (Kaunas, Lithuania) · 2020
   Review
5. Design, synthesis, and discovery of novel oxindoles bearing 3-heterocycles as species-specific and combinatorial agents in eradicating Staphylococcus species.Scientific reports · 2019
   Article

Corrections and comments

• Comment on
  A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.2018

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as